1. Home
  2. PTGX vs LMAT Comparison

PTGX vs LMAT Comparison

Compare PTGX & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$87.29

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$81.18

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTGX
LMAT
Founded
2006
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
1.9B
IPO Year
2016
2006

Fundamental Metrics

Financial Performance
Metric
PTGX
LMAT
Price
$87.29
$81.18
Analyst Decision
Strong Buy
Buy
Analyst Count
9
6
Target Price
$90.56
$101.83
AVG Volume (30 Days)
951.1K
180.0K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
0.96%
EPS Growth
N/A
27.40
EPS
0.72
2.32
Revenue
$209,217,000.00
$240,866,000.00
Revenue This Year
N/A
$15.17
Revenue Next Year
$288.98
$9.07
P/E Ratio
$121.16
$35.79
Revenue Growth
N/A
13.07
52 Week Low
$33.70
$71.42
52 Week High
$96.54
$105.55

Technical Indicators

Market Signals
Indicator
PTGX
LMAT
Relative Strength Index (RSI) 49.63 35.85
Support Level $84.11 $83.33
Resistance Level $89.61 $86.00
Average True Range (ATR) 2.97 2.12
MACD -0.69 -0.10
Stochastic Oscillator 25.58 0.14

Price Performance

Historical Comparison
PTGX
LMAT

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

Share on Social Networks: